Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Cambrex Corporation
Deal Watch: Aevi Options AstraZeneca Antibody For Rare Disease
Aevi needs to raise funds first, but hopes to develop MEDI2338 for adult-onset Still’s disease. Also, Alnylam plans to leverage Ironwood’s GI expertise for givosiran in acute hepatic porphyria and Ultragenyx snags option to buy GeneTx.
People Round-Up: Stada Brings In Consumer Expert To Lead German Business
Stada has turned to the FMCG world to find a head for its German operations, while former FDA commissioner Scott Gottlieb has linked up with Pfizer, and Nippon Kayaku has a new pharma head.
The Quality Lowdown: Quality Vision Falls Short At Various US and Indian Facilities
Court overrides stem cell clinic’s dismissal of drug GMPs, the US FDA upbraids drug makers for quality unit shortfalls, and a variety of snafus trigger drug recalls.
Manufacturing Round-Up: Sterling Gains A US Site As Normon Invests €100m
Sterling Pharma Solutions has acquired a US facility and Olon has bought a plant from Sandoz, while Normon is investing €100m in manufacturing expansions.
- Contract Research, Toxicology Testing-CRO
- Other Names / Subsidiaries
- Avista Pharma Solutions
- Halo Pharma
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.